This paper is only available as a PDF. To read, Please Download here.
Abstract
MR images of myelofibrosis were assessed in twelve patients. Myelofibrosis showed
low intensity in T1-weighted images, high intensity in STIR images, and enhancement
after gadolinium injection. MR spectroscopy detected a large water resonance. MR imaging
was consistent with histological findings and useful in evaluating the extracellular
space in bone marrow of myelofibrosis, but it was of no value in differentiating between
primary and secondary myelofibrosis.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinical ImagingAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Fibrosis of the bone marrow: content and causes.Br J Haematol. 1985; 59: 1-7
- The pathogenesis of myelofibrosis in myeloproliferative disorders.Ann Int Med. 1980; 92: 857-858
- MR imaging in myelofibrosis.J Comput Assist Tomogr. 1986; 10: 634-636
- Polycythemia vera and myelofibrosis: correlation of MR imaging, clinical, laboratory findings.Radiology. 1992; 183: 329-334
- Apparent focal bone marrow ischemia in patients with marrow disorders: MR studies.J Comput Assist Tomogr. 1993; 17: 792-797
- Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent.AJR. 1984; 142: 619-624
- Bone and bone-marrow blood flow in chronic granulocytic leukemia and primary myelofibrosis.J Nucl Med. 1982; 23: 218-224
- Controversy in the MR imaging appearance of fibrosis.Radiology. 1990; 177: 21-22
Article info
Publication history
Accepted:
January 17,
1996
Received:
December 2,
1995
Identification
Copyright
© 1997 Published by Elsevier Inc.
